EcoDrugPlus

Inosine Monophosphate Dehydrogenase 1

Ensembl ID : ENSOKIG00005029396
Gene Symbol: IMPDH1
1 Cross references
251 Possible Orthologues:

Inosine-5'-Monophosphate Dehydrogenase 1a-Like

Ensembl ID : ENSOKIG00005015999
Gene Symbol: LOC109867667
3 Cross references
251 Possible Orthologues:

Inosine-5'-Monophosphate Dehydrogenase 1b

Ensembl ID : ENSOKIG00005006612
Gene Symbol: LOC109878565
2 Cross references
254 Possible Orthologues:

Inosine-5'-Monophosphate Dehydrogenase 1b-Like

Ensembl ID : ENSOKIG00005035400
Gene Symbol: LOC109882102
3 Cross references
255 Possible Orthologues:

Inosine-5'-Monophosphate Dehydrogenase 2

Ensembl ID : ENSOKIG00005047785
Gene Symbol: LOC109869820
3 Cross references
194 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSOKIG00005036242
Gene Symbol: INSR
3 Cross references
204 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSOKIG00005032019
Gene Symbol: LOC109898192
3 Cross references
205 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSOKIG00005047213
Gene Symbol: INSR
3 Cross references
204 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSOKIG00005034602
Gene Symbol: LOC109874785
3 Cross references
204 Possible Orthologues:

Insulin-Like Growth Factor 1 Receptor

Ensembl ID : ENSOKIG00005037663
Gene Symbol: LOC109867238
3 Cross references
198 Possible Orthologues:

Insulin-Like Growth Factor 1a Receptor

Ensembl ID : ENSOKIG00005009694
Gene Symbol: IGF1RA
1 Cross references
197 Possible Orthologues:

Insulin-Like Growth Factor 1b Receptor

Ensembl ID : ENSOKIG00005034209
Gene Symbol: IGF1RB
1 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).